510(k) device
3D OCT-1 Maestro
Topcon Corporation · Tomography, Optical Coherence (OBO, Class II) · First FDA decision Jul 28, 2016, newest Mar 3, 2017GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
7
Naming "3D OCT-1 Maestro"
MAUDE reports
2
Brand "3D OCT-1 Maestro", since 2015
PubMed studies
1
Mentioning "3D OCT-1 Maestro"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- 3D OCT-1 Maestro510(k)
K170164 · Decided Mar 3, 2017 · 44 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- 3D OCT-1 Maestro510(k)
K161509 · Decided Jul 28, 2016 · 57 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "3D OCT-1 Maestro", any status and sponsor, newest update first.
- Assessment of an Automated Optical Coherence Tomography and Camera : Effectiveness of Vision-700Completed
Crystalvue Medical CoporationNot on our public-company list
NCT06496763 · 159 participants · Start Sep 1, 2022 · Primary completion Sep 1, 2022
Device: Vision-700 · For: Normal Subject; Glaucoma; Retinal Disease and 1 more
Sites: Taipei County, Taiwan
Topcon Medical Systems, Inc.Not on our public-company list
NCT02447133 · 12 participants · Start May 2015 · Primary completion May 2015
Device: 3D OCT-1 Maestro · For: Subjects Presenting With Normal Eyes
Sites: Oakland, New Jersey
- Clinical Study of the Optic Disc ParametersPivotal-lookingCompleted
Topcon Medical Systems, Inc.Not on our public-company list
NCT02277119 · 109 participants · Start Oct 2014 · Primary completion Jan 2015
Device: Maestro; iVue · For: Normal Healthy Subjects With No Known Ocular Diseases; Glaucomatous Eyes; Eyes With Retinal Diseases
Sites: Pomona, California; New York, New York
Topcon Medical Systems, Inc.Not on our public-company list
NCT02982174 · 15 participants · Start Dec 2016 · Primary completion Dec 2016
Device: 3D OCT-1 Maestro; DRI OCT Triton · For: Healthy Eyes
Sites: Oakland, New Jersey
- Triton Agreement and Precision StudyCompleted
Topcon Medical Systems, Inc.Not on our public-company list
NCT03080714 · 88 participants · Start Mar 13, 2017 · Primary completion Aug 30, 2017
Device: Topcon DRI OCT Triton (plus); 3D OCT-1 Maestro · For: Healthy Eyes; Eye Diseases
Sites: Willmar, Minnesota
Topcon Medical Systems, Inc.Not on our public-company list
NCT02447120 · 504 participants · Start May 2015 · Primary completion Oct 2015
Device: 3D OCT-1 Maestro · For: Healthy
Sites: Birmingham, Alabama; Fullerton, California; Livermore, California · 7 sites in all
Topcon Medical Systems, Inc.Not on our public-company list
NCT02376868 · 101 participants · Start May 2015 · Primary completion Sep 2015
Device: 3D OCT-1 Maestro; iVue · For: Normal Healthy Subjects With No Known Ocular Diseases; Glaucomatous Eyes; Eyes With Retinal Diseases
Sites: Pomona, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "3D OCT-1 Maestro", and for the whole product code for context.
This brand
2 reports: 0 malfunction, 2 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
- 3D OCT-1 MAESTROInjury
2242863-2024-00001 · Received Apr 15, 2024 · Event dated Mar 1, 2024
Device type: Tomography, Optical Coherence (OBO)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Convulsion/Seizure
- 3D OCT-1 MAESTROInjury
9614661-2024-00001 · Received Apr 15, 2024 · Event dated Mar 1, 2024
Device type: Tomography, Optical Coherence (OBO)
Device problem as coded: Use of Device Problem; Insufficient Device Problem Information
Patient problem as coded: Convulsion/Seizure
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "3D OCT-1 Maestro"[tiab]. The summary above synthesizes these.
- The development of a reference database with the Topcon 3D OCT-1 Maestro.
Chaglasian M, Fingeret M, Davey PG, et al. · Clin Ophthalmol · 2018
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- CIRRUS HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 510(k) 2024
- AnterionHeidelberg Engineering GmbH · 510(k) 2026
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.